SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
CleanCore Solutions appointed Tyler Hassen as CEO and board member to transition the company from cleaning products to AI infrastructure development, signing a non-binding LOI for …
Columbus McKinnon received auditor consent to incorporate Kito Crosby Limited's financial statements into existing Form S-8 registration statements. This filing facilitates the com…
Tyson Foods announced the appointment of Wes Morris as Chief Operating Officer effective June 15, 2026, with responsibility for all business segments including Chicken, Beef, Pork,…
OceanFirst Financial agreed to sell $1.4 billion of multifamily loans acquired in its June 1 Flushing Financial deal, reducing CRE concentration and NY rent-regulated exposure. The…
BioCardia sold 3.5M shares at $1.279 per share on June 5, 2026, raising $4.4M in net proceeds. The capital is intended to fund operations through Q1 2027 and support the company's …
Motorcar Parts of America reported strong fiscal 2026 fourth quarter results with net sales increasing 9.9% to $212.3 million and net income of $9.7 million compared to a net loss …
FuelCell Energy reported second quarter fiscal 2026 results with revenue of $35.6 million and a net loss per share of $(1.45), while advancing its data center power strategy with a…
Neurogene Inc. successfully completed enrollment in its Embolden registrational trial for NGN-401, dosing 25 participants (exceeding the 20-patient target) with no safety concerns …
Cipher Digital issued a presentation on June 1, 2026 outlining its Stingray Compute platform for bitcoin mining and high-performance computing data centers. The filing contains for…
Campbell's reported third quarter fiscal 2026 results with net sales down 4% to $2.4 billion and adjusted EBIT declining 24% to $274 million, though the company reaffirmed its full…
Quantum Space, a space defense and orbital mobility company, announced a definitive business combination agreement with SPAC Inflection Point Acquisition Corp. VI, valuing the comb…
Tango Therapeutics announced positive Phase 1/2 data showing a combination of its PRMT5 inhibitor vopimetostat and Revolution Medicines' RAS inhibitor daraxonrasib achieved 92% obj…
AstroNova posted $39.4 million in first quarter revenue with operating profit surging to $1.6 million and operating margins expanding 250 basis points to 4.0%, driven by 16.3% grow…
Seaport Therapeutics reported Q1 2026 financial results and announced new Phase 1 data for GlyphAgo showing therapeutic exposures without liver enzyme elevation concerns. The compa…
Graham Corporation delivered record quarterly and full-year fiscal 2026 results with revenue growth of 13% to $67.1M and 17% to $245.3M respectively, along with record backlog of $…
Ciena Corporation announced a proposed private offering of $2.0 billion in convertible senior notes due 2031, with an option for underwriters to purchase an additional $300 million…
Palladyne AI and Israel Aerospace Industries formed a strategic partnership giving Palladyne exclusive U.S. production and marketing rights for IAI's combat-proven loitering muniti…
Duluth Holdings reported a narrowing net loss of $10.0M versus $15.3M prior year, with gross margin expanding to 57.4% driven by reduced promotions and improved product costs. Stro…
Incyte agreed to acquire Vega Therapeutics, a Star Therapeutics subsidiary, to add VGA039, a Phase 3 bleeding disorder treatment candidate to its hematology portfolio. The deal exp…
Tonix Pharmaceuticals announced a second commercial payer agreement effective June 1, 2026, adding approximately 17 million U.S. lives in coverage for its fibromyalgia drug TONMYA,…